Yasumasa Masuda named CFO at Astellas
This article was originally published in Scrip
Astellas Pharma has appointed Yasumasa Masuda chief financial officer. Mr Masuda was previously Astellas' vice-president of corporate finance and control.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.